TY - JOUR
T1 - Graft-versus-host disease targets ovary and causes female infertility in mice
AU - Shimoji, Sonoko
AU - Hashimoto, Daigo
AU - Tsujigiwa, Hidetsugu
AU - Miyawaki, Kohta
AU - Kato, Koji
AU - Takahashi, Shuichiro
AU - Ogasawara, Reiki
AU - Jiromaru, Takashi
AU - Iwasaki, Hiromi
AU - Miyamoto, Toshihiro
AU - Akashi, Koichi
AU - Teshima, Takanori
N1 - Funding Information:
The authors thank Lifa Lee from the Department of Obstetrics and Gynecology, Yamaguchi University, and Fumio Otsuka from the Department of General Medicine, Okayama University, for expert technical assistance. This study was supported by Japan Society for the Promotion of Science KAKENHI (15K15358 and 25670443 [T.T.], and 26461438 [D.H.]), Promotion and Standardization of the Tenure-Track System (D.H.), and research grants from Astellas Foundation for Research on Metabolic Disorders (D.H.), Mochida Memorial Foundation for Medical and Pharmaceutical Research (K.K.), Takeda Science Foundation (D.H.), and SENSHIN Medical Research Foundation (D.H. and K.K.).
Publisher Copyright:
© 2017 by The American Society of Hematology.
PY - 2017/3/2
Y1 - 2017/3/2
N2 - Infertility associated with ovarian failure is a serious late complication for female survivors of allogeneic hematopoietic stem cell transplantation (SCT). Although pretransplant conditioning regimen has been appreciated as a cause of ovarian failure, increased application of reduced-intensity conditioning allowed us to revisit other factors possibly affecting ovarian function after allogeneic SCT. We have addressed whether donor T-cell-mediated graft-versus-host disease (GVHD) could be causally related to female infertility in mice. Histological evaluation of the ovaries after SCT demonstrated donor T-cell infiltration in close proximity to apoptotic granulosa cells in the ovarian follicles, resulting in impaired follicular hormone production and maturation of ovarian follicles. Mating experiments showed that female recipients of allogeneic SCT deliver significantly fewer newborns than recipients of syngeneic SCT. GVHD-mediated ovary insufficiency and infertility were independent of conditioning. Pharmacologic GVHD prophylaxis protected the ovary from GVHD and preserved fertility. These results demonstrate for the first time that GVHD targets the ovary and impairs ovarian function and fertility and has important clinical implications in young female transplant recipients with nonmalignant diseases, in whom minimally toxic regimens are used.
AB - Infertility associated with ovarian failure is a serious late complication for female survivors of allogeneic hematopoietic stem cell transplantation (SCT). Although pretransplant conditioning regimen has been appreciated as a cause of ovarian failure, increased application of reduced-intensity conditioning allowed us to revisit other factors possibly affecting ovarian function after allogeneic SCT. We have addressed whether donor T-cell-mediated graft-versus-host disease (GVHD) could be causally related to female infertility in mice. Histological evaluation of the ovaries after SCT demonstrated donor T-cell infiltration in close proximity to apoptotic granulosa cells in the ovarian follicles, resulting in impaired follicular hormone production and maturation of ovarian follicles. Mating experiments showed that female recipients of allogeneic SCT deliver significantly fewer newborns than recipients of syngeneic SCT. GVHD-mediated ovary insufficiency and infertility were independent of conditioning. Pharmacologic GVHD prophylaxis protected the ovary from GVHD and preserved fertility. These results demonstrate for the first time that GVHD targets the ovary and impairs ovarian function and fertility and has important clinical implications in young female transplant recipients with nonmalignant diseases, in whom minimally toxic regimens are used.
UR - http://www.scopus.com/inward/record.url?scp=85014938103&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85014938103&partnerID=8YFLogxK
U2 - 10.1182/blood-2016-07-728337
DO - 10.1182/blood-2016-07-728337
M3 - Article
C2 - 27903524
AN - SCOPUS:85014938103
SN - 0006-4971
VL - 129
SP - 1216
EP - 1225
JO - Blood
JF - Blood
IS - 9
ER -